[1] ZHANG JingwenFAN XianlingWANG NanZHANG Ziteng?YANG Yifan?JIA NiYAN Yongmei,.Research Progress in Chinese Medicine Treatment of Parkinson’s Disease Based on Cell Autophagy [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2024, (01): 1-6. [doi: 10.13424/j.cnki.jsctcm.2024.01.001]
Research Progress in Chinese Medicine Treatment of Parkinson’s Disease Based on Cell Autophagy
- Article number:
- 2096-1340(2024)01-0001-06
- Keywords:
- Key words： Cellular autophagy; Parkinson’s disease; Traditional Chinese Medicine; Research progress
- ZTFLH:
- R277.7
- Code:
- A
- Abstract:
- Abstract： Existing research has confirmed that impaired autophagy may play an important role in the pathogenesis of Parkinsons disease (PD).Traditional Chinese medicine has rich experience in the treatment of PD degenerative nervous system diseases.By reviewing the scientific understanding of the role of traditional Chinese medicine in the pathogenesis of PD and autophagy dysfunction,and exploring the potential of traditional Chinese medicine in regulating autophagy process,we can provide new treatment methods for PD patients.
References:
［1］Tysnes OB,Storstein A.Epidemiology of Parkinson’s disease［J］.Journal of Neural Transmission,2017,124(8): 901-905.
［2］沈凡艺,陈子方,吴海妹,等.帕金森病发病机制研究进展［J］.中国民族民间医药,2020,29(22):60-64.
［3］Lizama BN,Chu CT.Neuronal autophagy and mitophagy in Parkinson’s disease［J］.Molecular Aspects of Medicine,2021,82:100972.
［4］Losmanová T,Janser FA,Humbert M,et al.Chaperonemediated autophagy markers LAMP2A and HSC70 are independent adverse prognostic markers in primary resected squamous cell carcinomas of the lung［J］.Oxidative Medicine and Cellular Longevity,2020,2020:8506572.
［5］Tang QL,Gao P,Arzberger T,et al.AlphaSynuclein defects autophagy by impairing SNAP29mediated autophagosomelysosome fusion［J］.Cell Death & Disease,2021,12（10）:854.
［6］Di Maio R,Hoffman EK,Rocha EM,et al.LRRK2 activation in idiopathic Parkinson’s disease［J］.Science Translational Medicine,2018,10(451):eaar5429.
［7］Pang SYY,Lo RCN,Ho PWL,et al.LRRK2,GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson’s disease［J］.Translational Neurodegeneration,2022,11(1):5.
［8］Pradas E,MartinezVicente M.The consequences of GBA deficiency in the autophagylysosome system in Parkinsons disease associated with GBA［J］.Cells,2023,12(1):191.
［9］De Lazzari F,Agostini F,Plotegher N,et al.DJ1 promotes energy balance by regulating both mitochondrial and autophagic homeostasis［J］.Neurobiology of Disease,2023,176:105941.
［10］Fowler AJ, Moussa CEH.Activating autophagy as a therapeutic strategy for Parkinson’s disease［J］.CNS Drugs,2018,32(1):111.
［11］Liu KY,Shi N,Sun YY,et al.Therapeutic effects of rapamycin on MPTPinduced Parkinsonism in mice［J］.Neurochemical Research,2013,38(1):201-207.
［12］颜培正,张庆祥,王诗源,等.气与细胞自噬的相关性［J］.中医杂志,2019,60(2):111-113,122.
［13］颜培正,王晓旭,张庆祥,等.肺气虚与细胞自噬的相关性研究［J］.辽宁中医杂志,2019,46(10):2061-2064.
［14］王学林,栾振先,李晨,等.论肠道微环境是补肾活血法治疗帕金森病的重要靶点［J］.陕西中医药大学学报,2022,45(1):42-47.
［15］杨良俊,刘伟,胡志鹏,等.基于脾胃理论探讨脾气虚病机与细胞自噬功能紊乱的相关性［J］.南京中医药大学学报,2019,35(1):5-8.
［16］郭旭堂,梁健芬,张新博.从痰瘀机制探讨自噬在帕金森病发展中的作用［J］.中华中医药杂志,2015,30(4):1201-1204.
［17］胡朋言,王伟,梁雪,等.细胞自噬与相关中医辨证体系的研究进展［J］.中华中医药学刊,2018,36(9):2217-2219.
［18］黄丽琼,黄贵华,纪云西,等.细胞自噬与中医“阴阳”及“气”理论相关性探讨［J］.辽宁中医杂志,2014,41(6):1147-1149.
［19］王佳彬,沈晓明,马云枝,等.帕金森病中西医研究进展［J］.中国实验方剂学杂志,2022,28(1):241-250.
［20］黎铭玉,周巍,周兰,等.基于中医阴阳理论探讨针灸对细胞自噬的调节作用及意义［J］.湖南中医药大学学报,2020,40(11):1427-1431.
［21］黄宁静,李如奎,李文涛.中医药调节自噬途径治疗帕金森病的作用机制［J］.中西医结合心脑血管病杂志,2016,14(20):2453-2455.
［22］陈茜琳,曾常茜.川芎与神经退行性疾病［J］.中国医药指南,2021,19(21):14-15.
［23］林承列,田甜,吴焕淦,等.针灸对细胞自噬水平的调控及其在神经退行性疾病中的作用［J］.世界中医药,2016,11(12):2566-2570.
［24］刘展,蔡美云,庄文欣,等.山柰酚通过mTOR通路诱导细胞自噬保护帕金森病模型小鼠多巴胺能神经元［J］.中药新药与临床药理,2022,33(4):446-453.
［25］程宝仓,夏昱,杨会杰,等.石菖蒲挥发油对帕金森病模型小鼠黑质多巴胺能神经元自噬的影响及其机制［J］.卒中与神经疾病,2022,29(2):101-105,137.
［26］吴忧,梁顺利,徐彬,等.姜黄素通过抑制PI3K/Akt/mTOR通路增强自噬保护帕金森病细胞模型的研究［J］.中国现代应用药学,2021,38(19):2351-2358.
［27］Wu YC,Li XQ,Zhu JX,et al.Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson’s disease［J］.NeuroSignals,2011,19(3):163-174.
［28］王春玲,罗宁,文晓东,等.乌梅总黄酮通过线粒体自噬对帕金森病大鼠的保护作用［J］.西部中医药,2022,35(12):72-76.
［29］王辉,任秀君,谭小宇.穿心莲内酯通过诱导线粒体自噬对实验性帕金森病小鼠改善作用研究［J］.临床和实验医学杂志,2022,21(2):117-122.
［30］牟蕾,高代丽,王利振,等.小檗碱衍生物9- OH小檗碱的抗帕金森病活性和作用机制研究［J］.中国医院药学杂志,2022,42(9):884-888.
［31］刘京京,高鑫,卢芳,等.平肝益肾方对MPP+损伤SH-SY5Y细胞自噬及相关蛋白表达的影响［J］.世界中西医结合杂志,2020,15(12):2246-2251.
［32］黄宁静,Wei Jianning,李文涛.止颤汤参与帕金森病大鼠自噬途径中P62调节α-突触核蛋白的研究［J］.中西医结合心脑血管病杂志,2017,15(21):2689-2692.
［33］李茜羽,姚淑红,陈小倩,等.苁蓉舒痉颗粒对帕金森病模型大鼠中脑线粒体氧化应激及自噬相关SIRT1/FoxO通路的影响［J］.福建中医药,2022,53(3):26-30.
［34］张兴博,梁健芬,陈炜,等.加味五虎追风散通过调控TFEB介导的自噬干预帕金森病发病的实验研究［J］.中西医结合心脑血管病杂志,2021,19(5):758-760.
［35］吴忧,朱虹,张厚文,等.菖蒲郁金汤对帕金森病小鼠的神经保护作用及机制探讨［J］.浙江中医药大学学报,2022,46(10):1070-1076,1085.
［36］韦一佛,陈路,张亚男,等.滋肾益髓方对帕金森病小鼠分子伴侣介导的自噬途径的影响［J］.中华中医药杂志,2018,33(9):4122-4124.
［37］彭伟,张立娟,张倩,等.天麻钩藤饮对帕金森病模型大鼠纹状体α-突触核蛋白含量及自噬相关蛋白Beclin1、LC3B表达的影响［J］.中医杂志,2018,59(14):1228-1231.
［38］高鑫,王一晴,卢芳,等.拜颤停复方对MPP+诱导SH-SY5Y细胞自噬及凋亡机制研究［J］.中医药信息,2022,39(7):27-32.
［39］王春玲,罗宁,蒋媛静,等.基于CaMkkβ/AMPK通路介导线粒体自噬探讨敛肝熄风止颤方的神经保护机制［J］.世界中医药,2021,16(5):765-768,774.
［40］常学辉,张良芝,李天佛.龟羚帕安丸对帕金森病大鼠中脑黑质病理、Beclin1、P62及LC3Ⅱ影响的研究［J］.中华中医药学刊,2021,39(1):5-7,261.
［41］吴海洋,刘秀秀,王颖,等.通督调神针刺对帕金森病模型小鼠线粒体自噬水平和多巴胺含量的影响［J］.时珍国医国药,2022,33(6):1496-1500.
［42］符之逸.基于Nrf2调控自噬探讨电针改善MPTP诱导帕金森病模型小鼠运动功能障碍的机制［D］.广州:南方医科大学,2022.
［43］罗宇雄,黄永光,许石隆,等.埋线疗法改善帕金森病症状的机制研究［J］.中医外治杂志,2023,32(1):1-3.
［44］马骏,余沛豪,王述菊,等.电针对帕金森病模型大鼠脑黑质内Lamp2a、Hsc70、α-syn表达的影响［J］.中华中医药学刊,2018,36(4):859-862.
Memo
基金项目：国家中医药管理局中医药科学技术研究专项课题（GYZ-KJS-2021-001）；陕西省科技厅重点研发计划项目（S2021-YF-ZDCXL-ZDLSF-0011）；陕西省科技厅重点研发计划项目（2020ZDLSF05-14)；陕西省中医药管理局中西医结合临床协作创新项目(2020-ZXY-002)；陕西中医药大学附属医院中医临床基地建设项目(2020LCJD003 )；陕西中医药大学附属医院中医临床基地建设项目(2020LCJD007)